Skip to content

Pulmonx Corporation LUNG Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$13.65M-31.0%-$10.43M+25.3%-$13.96M+8.0%-$15.17M-5.0%-$14.45M-9.7%
$220K-4.8%$231K-6.1%$246K-17.7%$299K+7.6%$278K-5.4%
$4.14M-2.5%$4.24M-17.9%$5.17M-16.9%$6.21M+10.7%$5.61M+1.6%
-$4K$0-100%
$46K+207%$15K+7.1%$14K+7.7%$13K+18.2%$11K0.0%
-$1.2M+25.0%-$1.61M-13.9%-$1.41M-216%$1.22M+69.2%$721K-58.6%
$959K+18.4%$810K-20.7%$1.02M+255%-$660K-62.6%-$406K-365%
-$430K$121K-94.3%$2.14M+324%$505K
-$1.17M-163%-$443K-$4.89M-223%
-$61K$369K-25.8%
$14K+119%-$73K-$53K-563%-$8K-128%
$51K-53.2%$109K$0-100%$68K+183%$24K+233%
$415K+12.8%$368K-20.9%$465K+82.4%$255K-29.2%$360K+8.1%
-$107K$0
-$329K-17.1%-$281K+26.2%-$381K-48.8%-$256K-592%-$37K
-$10.1M-42.5%-$7.08M+13.2%-$8.16M-109%-$3.91M+70.4%-$13.22M-96.5%
$9K-30.8%$13K-85.4%$89K+81.6%$49K-83.7%$301K+171%
$0$1.73M-55.9%$3.92M+162%
$0$0-100%$8.8M+21.4%$7.25M-64.7%$20.54M+31.0%
-$9K$0-100%$8.71M+59.2%$5.47M-66.5%$16.31M+16.0%
$38.79M$0
$37M+72,449%$51K+5,000%$1K-97.9%$48K$0-100%
$40K-62.3%$106K+2,020%$5K-82.1%$28K-74.5%$110K0.0%
$2.03M+3,584%$55K-69.6%$181K$0-100%$664K+971%
-$100K-$583K-455%-$105K-154%
-$8.18M-20.3%-$6.8M-727%$1.09M+18.8%$913K-75.0%$3.65M
$789K+5.3%$749K-5.4%$792K+1.0%$784K-0.5%$788K-4.0%
$76K-26.9%$104K-30.7%$150K+42.9%$105K-3.7%$109K+14.7%
$0$0-100%$40K-69.9%$133K-35.4%$206K-39.4%
$46K+207%$15K+7.1%$14K+7.7%$13K+18.2%$11K0.0%
-$4K$0-100%
-$329K-17.1%-$281K+26.2%-$381K-48.8%-$256K-592%-$37K
$29K+105%-$627K-$791K-157%-$308K-328%
$144K-13.8%$167K+132%$72K+244%-$50K-8.7%-$46K
$415K+12.8%$368K-20.9%$465K+82.4%$255K-29.2%$360K+8.1%
$220K-4.8%$231K-6.1%$246K-17.7%$299K+7.6%$278K-5.4%
$67K$0
$0$0-100%$8.8M+21.4%$7.25M-64.7%$20.54M+31.0%
$38.79M$0
$201K$200K$554K+55,300%
$37M$0
$0$66K+633%$9K
$400K$0
$14K+119%-$73K-$53K-563%-$8K-128%
-$329K-17.1%-$281K+26.2%-$381K-48.8%-$256K-592%-$37K
$1.38M$0
$76K-26.9%$104K-30.7%$150K+42.9%$105K-3.7%$109K+14.7%
-$10.11M-42.4%-$7.1M+14.0%-$8.25M-109%-$3.96M+70.7%-$13.52M-97.7%
-$10.11M-42.4%-$7.1M+14.0%-$8.25M-109%-$3.96M+70.7%-$13.52M-97.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Pulmonx Corporation generate?
Pulmonx Corporation (LUNG) generated -$29.3M in operating cash flow over the trailing twelve months.
What is Pulmonx Corporation's free cash flow?
After $160.0K of capital expenditures, Pulmonx Corporation's free cash flow was -$29.4M over the trailing twelve months, up 14.2% year over year.
Where does Pulmonx Corporation's cash flow data come from?
Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.